Spondyloarthropathies News

SAN DIEGO – Certain HLA alleles appear to safeguard against sacroiliitis among patients with psoriatic arthritis, while others may increase an individual’s likelihood of developing the condition, according to findings presented at the American College of Rheumatology Annual Meeting.

SAN DIEGO — Bone marrow edema is common in the sacroiliac joints of both amateur and professional young athletes, with damage most frequently seen in the posterior lower ilium, according to research presented at the American College of Rheumatology Annual Meeting.

SAN DIEGO – A physical exam and complete medical history should supplement MRI results when making a diagnosis of spondyloarthritis, according to findings presented at the ACR Annual Meeting.

Results of this retrospective study showed a positive association between disease activity, allogeneic blood transfusion volume and change of hematocrit concentration from preoperatively to postoperatively with perioperative blood loss among patients with ankylosing spondylitis undergoing total hip arthroplasty.

SAN DIEGO — Secukinumab provided sustained improvements in signs and symptoms of ankylosing spondylitis among patients who completed three years of treatment, according to data presented at the American College of Rheumatology Annual Meeting.

SAN DIEGO – Treatment with ABBV-066, a monoclonal antibody that inhibits interleukin-23, provided substantial improvements in joint and skin scores among patients with psoriatic arthritis, according to findings presented at the American College of Rheumatology Annual Meeting.

SAN DIEGO – Treatment with adalimumab led to remission and sustained disease control among patients with non-radiographic axial spondyloarthropathy, according to findings presented at the American College of Rheumatology Annual Meeting.

SAN DIEGO — Although sacroiliac MRI has been extensively relied on to diagnose axial spondyloarthritis, research presented at the American College of Rheumatology Annual Meeting demonstrated that similar inflammation of sacroiliac joints was observed among even healthy individuals, highlighting the need for complementary diagnostic measures.

SAN DIEGO — Patients with both obesity and axial spondyloarthropathy have higher disease activity, worse physical function and lower quality of life, according to data from a press release issued at the American College of Rheumatology Annual Meeting.

Janssen announced it has received FDA approvals for Simponi Aria for the treatment of adults with psoriatic arthritis or active ankylosing spondylitis, according to a company press release.